(RO) Roche Holding - Performance 23% in 12m
Compare RO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
0.04%
#58 in Group
Rel. Strength
78.34%
#1730 in Universe
Total Return 12m
23.04%
#36 in Group
Total Return 5y
-0.52%
#65 in Group
P/E 26.2
71th Percentile in Group
P/E Forward 13.2
45th Percentile in Group
PEG 0.66
36th Percentile in Group
FCF Yield 7.90%
76th Percentile in Group
12m Total Return: RO (23%) vs XLV (0.8%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-35.9% | 213% | 500% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
7.18% | 20.9% | 513% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.77% | 21.1% | 76.1% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 11.5% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-3.71% | 9.8% | 50.6% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.67% | 3.11% | 56.4% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-7.55% | 6.86% | 24.4% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SNY NASDAQ Sanofi |
-3.14% | 14.1% | 34% | 18.5 | 11.2 | 0.9 | -52.5% | -47% |
Performance Comparison: RO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RO
Total Return (including Dividends) | RO | XLV | S&P 500 |
---|---|---|---|
1 Month | -6.07% | -4.61% | -0.91% |
3 Months | -0.88% | -4.01% | -7.61% |
12 Months | 23.04% | 0.78% | 10.06% |
5 Years | -0.52% | 54.00% | 110.82% |
Trend Score (consistency of price movement) | RO | XLV | S&P 500 |
1 Month | -22.7% | -23.1% | 1.2% |
3 Months | -29.7% | -69% | -89.2% |
12 Months | 48.3% | -15.8% | 56.2% |
5 Years | -31.0% | 89.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #124 | -1.53% | -5.21% |
3 Month | #59 | 3.26% | 7.29% |
12 Month | #36 | 22.1% | 11.8% |
5 Years | #67 | -35.4% | -52.7% |
FAQs
Does RO Roche Holding outperforms the market?
Yes,
over the last 12 months RO made 23.04%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.78%.
Over the last 3 months RO made -0.88%, while XLV made -4.01%.
Over the last 3 months RO made -0.88%, while XLV made -4.01%.
Performance Comparison RO vs Indeces and Sectors
RO vs. Indices RO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.91% | -5.16% | 1.99% | 13.0% |
US NASDAQ 100 | QQQ | -0.95% | -7.48% | 2.51% | 12.5% |
US Dow Jones Industrial 30 | DIA | 2.64% | -2.62% | 1.22% | 15.8% |
German DAX 40 | DAX | 0.71% | -7.18% | -17.1% | -0.09% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.85% | -3.47% | 3.06% | 18.1% |
Hongkong Hang Seng | HSI | 4.26% | -4.07% | 0.96% | 12.9% |
India NIFTY 50 | INDA | 5.97% | -10.1% | 0.26% | 20.4% |
Brasil Bovespa | EWZ | 0.24% | -11.9% | -3.59% | 29.9% |
RO vs. Sectors RO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.59% | -4.99% | -6.08% | 1.18% |
Consumer Discretionary | XLY | -0.89% | -6.89% | -2.0% | 11.5% |
Consumer Staples | XLP | 7.26% | -5.54% | -4.46% | 13.1% |
Energy | XLE | 4.39% | 5.40% | 2.17% | 34.4% |
Financial | XLF | 2.84% | -3.78% | -6.67% | 1.77% |
Health Care | XLV | 2.92% | -1.46% | 3.24% | 22.3% |
Industrial | XLI | 1.51% | -5.47% | 1.04% | 16.0% |
Materials | XLB | 3.48% | -3.14% | 8.33% | 28.8% |
Real Estate | XLRE | 4.33% | -4.30% | 2.43% | 7.66% |
Technology | XLK | -2.61% | -7.34% | 7.96% | 18.1% |
Utilities | XLU | 4.37% | -6.64% | -3.69% | 1.23% |
Aerospace & Defense | XAR | -1.44% | -13.0% | -10.7% | -2.98% |
Biotech | XBI | 0.58% | -7.03% | 14.8% | 27.2% |
Homebuilder | XHB | 4.19% | -2.97% | 16.0% | 32.5% |
Retail | XRT | 3.35% | -5.94% | 5.85% | 27.2% |